SCHEMBL23648684

SCHEMBL23648684

CC1(C)Nc2cncc(F)c2NC1=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8655583 0.53 — —
SCHEMBL22658936 0.49 LPL (0.40) —
SCHEMBL19249969 0.48 TDO2 (0.33) —
SCHEMBL14157127 0.48 KCNQ2 (0.35) —
SCHEMBL10079569 0.48 CYP11B2 (0.38) —
SCHEMBL14879427 0.48 — —
SCHEMBL617427 0.48 — —
SCHEMBL27387671 0.47 CYP11B2 (0.41) —
SCHEMBL4374787 0.47 TDP1 (0.38) —
SCHEMBL21598602 0.46 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4090661-B1 QUINOXALINE DERIVATIVES AS MODULATORS OF THE GLUCOCORTICOID RECEPTOR GRUENENTHAL GMBH (DE) 2025-03-12 — — EP disclosed
US-20220372041-A1 QUINOXALINE DERIVATIVES GRUENENTHAL GMBH (DE) 2022-11-24 — — US disclosed
EP-4090661-A1 QUINOXALINE DERIVATIVES AS MODULATORS OF THE GLUCOCORTICOID RECEPTOR Grünenthal GmbH (DE) 2022-11-23 — — EP disclosed
WO-2021144440-A1 QUINOXALINE DERIVATIVES AS MODULATORS OF THE GLUCOCORTICOID RECEPTOR Grünenthal GmbH (DE) 2021-07-22 — — WO disclosed
WO-2021144440-A1 QUINOXALINE DERIVATIVES AS MODULATORS OF THE GLUCOCORTICOID RECEPTOR Grünenthal GmbH (DE) 2021-07-22 — — WO disclosed
Send feedback